Acinetobacter baumannii has emerged in the last decades as a major cause of healthcare-associated infections and nosocomial outbreaks. Multidrug-resistant (MDR) A. baumannii is a rapidly emerging ...

owing to resistance developed during and after treatment. The combination of antibiotics with different activities against MDR A. baumannii will probably represent the main resource for these ...

Novel CDSCO and US FDA approved pneumonia drugs to ease public health challenge: Nandita Vijayasimha., Bengaluru Friday, December 13, 2024, 08:00 Hrs [IST] Indian healthcare provi ...

Dietary zinc deficiency promotes lung infection by Acinetobacter baumannii ... Anti-IL-13 antibody treatment protected zinc-deficient mice from A. baumannii-induced death. The findings add to ...

New research has shown that a lack of dietary zinc can boost the chances of a lung infection caused by Acinetobacter baumannii bacteria ... many of which are resistant to drug treatment. This includes ...

Dietary zinc deficiency promotes lung infection by Acinetobacter baumannii ... Anti-IL-13 antibody treatment protected zinc-deficient mice from A. baumannii-induced death. The findings add to ...

Anti-IL-13 antibody treatment protected zinc-deficient ... Dietary zinc deficiency promotes Acinetobacter baumannii lung infection via IL-13 in mice, Nature Microbiology (2024).

These bacteria have evolved the ability to resist treatment with antibiotics, and it's making them more deadly and harder to ...

Antibacterial drugs are important for treating infections. But increasingly, bacterial resistance to current drugs—so they ...

A lack of effective antibiotics for harmful bacteria such as Acinetobacter baumannii and Mycobacterium ... potential to create a paradigm shift in treatment options for AMR.” ...